We are live on ! Find out more
MREO

Mereo BioPharma
MREO

66 hedge funds and large institutions have $305M invested in Mereo BioPharma in 2021 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

190% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 10

143% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 7

49% more capital invested

Capital invested by funds: $205M → $305M (+$99.6M)

42% more call options, than puts

Call options by funds: $1.15M | Put options by funds: $810K

40% more funds holding

Funds holding: 47 → 66 (+19)

0.56% more ownership

Funds ownership: 13.13% → 13.69% (+0.56%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
66
Holders Change
+19
Holders Change %
+40.43%
% of All Funds
1.16%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
29
Increased
17
Reduced
7
Closed
10
Calls
$1.15M
Puts
$810K
Net Calls
+$337K
Net Calls Change
+$337K

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$29.3M
2
PA
Perceptive Advisors
New York
+$21.2M
3
RSCM
Rock Springs Capital Management
Maryland
+$15.9M
4
SCM
Suvretta Capital Management
New York
+$12.8M
5
Millennium Management
Millennium Management
New York
+$8.58M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$5.93M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$5.62M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$4M
4
TLP
Tri Locum Partners
New York
-$2.61M
5
Holocene Advisors
Holocene Advisors
New York
-$2.07M
Name Holding Trade Value Shares
Change 		Change in
Stake
Cetera Investment Advisers
51
Cetera Investment Advisers
Illinois
$48K +$49.8K +14,100 New
SFI
52
Susquehanna Fundamental Investments
Pennsylvania
$44K +$7.07K +2,000 +18%
CL
53
CSS LLC
Illinois
$36K -$14.1K -4,000 -27%
CCM
54
CAAS Capital Management
New York
$34K +$35.3K +10,000 New
VFA
55
Valeo Financial Advisors
Indiana
$25K +$26.5K +7,500 +125,000%
Simplex Trading
56
Simplex Trading
Illinois
$24K +$26.1K +7,379 New
UBS Group
57
UBS Group
Switzerland
$17K +$1.7K +480 +10%
NFSG
58
Newbridge Financial Services Group
Florida
$13K +$14.1K +4,000 New
Wells Fargo
59
Wells Fargo
California
$11K +$10.6K +3,000 +1,304%
TCWM
60
Total Clarity Wealth Management
Illinois
$7K +$7.6K +2,150 New
SPIA
61
Steward Partners Investment Advisory
New York
$6.74K +$7.07K +2,000 New
Bank of America
62
Bank of America
North Carolina
$6K – – –
EWM
63
Endurance Wealth Management
Rhode Island
$5K +$5.3K +1,500 New
SIA
64
Sit Investment Associates
Minnesota
$3K – – –
Rockefeller Capital Management
65
Rockefeller Capital Management
New York
$1K – – –
BlackRock
66
BlackRock
New York
$1K +$583 +165 New
Schroder Investment Management Group
67
Schroder Investment Management Group
United Kingdom
– -$5.62M -1,569,174 Closed
Janus Henderson Group
68
Janus Henderson Group
United Kingdom
– -$4M -1,124,678 Closed
TLP
69
Tri Locum Partners
New York
– -$2.61M -728,710 Closed
VF
70
Virtu Financial
New York
– -$215K -59,966 Closed
PCM
71
Prelude Capital Management
New York
– -$188K -52,521 Closed
NFC
72
Northeast Financial Consultants
Connecticut
– -$60K -16,667 Closed
LC
73
Lindbrook Capital
California
– -$18K -5,000 Closed
Royal Bank of Canada
74
Royal Bank of Canada
Ontario, Canada
– -$7K -2,000 Closed
Osaic Holdings
75
Osaic Holdings
Arizona
– -$1K -410 Closed
1 2
3
4

MREO Hedge Fund Activity: Q1 2021 in Review

66 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Mereo BioPharma (MREO) for Q1 2021, worth a combined $305M — up 49% from $205M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new MREO positions and 10 closed out — a net gain of 19 holders — while 17 added to existing stakes and 7 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $29.3M. The largest seller was Citadel Advisors, cutting an estimated $5.93M.

  • 66 institutional investors held Mereo BioPharma (MREO) as of Q1 2021, up from 47 in Q4 2020.
  • Funds reported $305M of Mereo BioPharma stock for Q1 2021, up 49% quarter-over-quarter.
  • 29 funds opened new Mereo BioPharma positions in Q1 2021 and 10 closed out, a net change of +19 holders.
  • The largest Mereo BioPharma buyer in Q1 2021 was Point72 Asset Management, an estimated $29.3M added.
  • The largest Mereo BioPharma seller in Q1 2021 was Citadel Advisors, an estimated $5.93M sold.

Based on aggregated 13F filings for Q1 2021.